Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Deferred Stock Units

Director Charles D. Baker reports acquisition of 168 deferred stock units of UnitedHealth Group as part of quarterly compensation.

Summary

• Charles D. Baker, a director of UnitedHealth Group, reported acquiring 168 shares of common stock on April 1, 2025.
• These shares are in the form of deferred stock units granted as quarterly compensation for his service as a director.
• The price of the acquired stock is $0.
• The deferred stock units are immediately vested but must be retained until completion of service on the Board.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating stable corporate governance practices. The sentiment is neutral to slightly positive.

Positives

• The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
• The vesting schedule encourages continued service on the Board.

Future Outlook

The document does not contain specific forward-looking statements beyond the standard terms of director compensation.

Industry Context

Director compensation through stock grants is a common practice in publicly traded companies to align management interests with shareholder value.

Comparison to Industry Standards

• Director compensation packages vary across the healthcare industry.
• Companies like CVS Health, Anthem (now Elevance Health), and Cigna also utilize stock grants and options as part of their director compensation.
• The specific amount and vesting schedules depend on company size, performance, and board responsibilities.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It reinforces the alignment of director interests with shareholder value.

Key Dates

Keywords

UnitedHealth Group, Director Compensation, Deferred Stock Units, Form 4, Beneficial Ownership, UNH, Baker